Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/08/2023 | AGILE THERAPEUTICS INC | AGRX | Grant | Common Stock | 935 | $0.00 | $0 | | 06/08/2023 |
06/08/2023 | AGILE THERAPEUTICS INC | AGRX | Grant | Employee Stock Option (Right to Buy) | 1.1k | $3.58 | $3.8k | | 06/08/2023 |
08/10/2022 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 20.5k | $0.31 | $6.4k | | 08/10/2022 |
06/09/2022 | AGILE THERAPEUTICS INC | AGRX | Grant | Common Stock | 670 | $0.00 | $0 | | 06/09/2022 |
06/09/2022 | AGILE THERAPEUTICS INC | AGRX | Grant | Employee Stock Option (Right to Buy) | 807 | $1.22 | $984.5 | | 06/09/2022 |
07/19/2021 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 20.5k | $2.75 | $56.4k | | 07/19/2021 |
06/08/2021 | AGILE THERAPEUTICS INC | AGRX | Grant | Employee Stock Option (Right to Buy) | 29.9k | $1.53 | $45.8k | | 06/08/2021 |
06/08/2021 | AGILE THERAPEUTICS INC | AGRX | Grant | Common Stock | 24.5k | $0.00 | $0 | | 06/08/2021 |
08/20/2020 | VYNE Therapeutics Inc. | MNLO | Exercise | Stock Options | 75k | $1.48 | $111k | | 08/20/2020 |
08/03/2020 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 22.5k | $1.72 | $38.7k | | 08/03/2020 |
06/09/2020 | AGILE THERAPEUTICS INC | AGRX | Grant | Common Stock | 26.8k | $0.00 | $0 | | 06/09/2020 |
06/09/2020 | AGILE THERAPEUTICS INC | AGRX | Grant | Employee Stock Option (Right to Buy) | 45.2k | $2.80 | $126.6k | | 06/09/2020 |
03/19/2020 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Option | 45k | $2.67 | $120.2k | | 03/19/2020 |
03/09/2020 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 29.3k | $4.50 | $131.7k | | 03/09/2020 |
03/09/2020 | Foamix Pharmaceuticals Ltd. | FOMX | Disposition | Options | 49.4k | $2.66 | $131.4k | | 03/09/2020 |
05/16/2019 | Foamix Pharmaceuticals Ltd. | FOMX | Grant | | 49.4k | $2.66 | $131.4k | | 05/16/2019 |
03/01/2018 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Common Stock, $0.0001 par value per share | 1.4k | $0.00 | $0 | | 03/01/2018 |
01/02/2018 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Common Stock, $0.0001 par value per share | 17.2k | $0.00 | $0 | | 01/02/2018 |
11/29/2017 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Common Stock, $0.0001 par value per share | 13.9k | $0.00 | $0 | | 11/29/2017 |
08/29/2017 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Common Stock, $0.0001 par value per share | 880 | $0.00 | $0 | | 08/29/2017 |
05/30/2017 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Common Stock, $0.0001 par value per share | 754 | $0.00 | $0 | | 05/30/2017 |
02/23/2016 | CYTOKINETICS INC | CYTK | Grant | Non-Qualified Stock Option (right to buy) | 75k | $6.67 | $500.2k | | 02/23/2016 |
02/23/2016 | CYTOKINETICS INC | CYTK | Grant | Incentive Stock Option (right to buy) | 15k | $6.67 | $100.1k | | 02/23/2016 |
11/30/2015 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Stock Options (Rights to Buy) | 4.9k | $1.24 | $6.1k | | 11/30/2015 |
08/31/2015 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Stock Options (Rights to Buy) | 5.1k | $1.21 | $6.2k | | 08/31/2015 |
06/01/2015 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Stock Options (Rights to Buy) | 7k | $0.90 | $6.3k | | 06/01/2015 |
03/02/2015 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Stock Options (right to buy) | 7.2k | $0.86 | $6.2k | | 03/02/2015 |
02/26/2015 | CYTOKINETICS INC | CYTK | Grant | Non-Qualified Stock Option (right to buy) | 62.8k | $7.96 | $500.3k | | 02/26/2015 |
02/26/2015 | CYTOKINETICS INC | CYTK | Grant | Incentive Stock Option (right to buy) | 12.2k | $7.96 | $96.7k | | 02/26/2015 |
12/01/2014 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Stock Options (right to buy) | 4.5k | $1.40 | $6.2k | | 12/01/2014 |
07/15/2014 | Sonoma Pharmaceuticals, Inc. | SNOA | Grant | Stock Options (right to buy) | 2.3k | $2.68 | $6.1k | | 07/15/2014 |
02/24/2014 | CYTOKINETICS INC | CYTK | Grant | Non-Qualified Stock Option (right to buy) | 57.3k | $9.65 | $552.6k | | 02/24/2014 |
02/24/2014 | CYTOKINETICS INC | CYTK | Grant | Incentive Stock Option (right to buy) | 12.7k | $9.65 | $122.9k | | 02/24/2014 |
03/05/2013 | CYTOKINETICS INC | CYTK | Grant | Non-Qualified Stock Option (right to buy) | 165.3k | $1.00 | $165.3k | | 03/05/2013 |
03/05/2013 | CYTOKINETICS INC | CYTK | Grant | Incentive Stock Option (right to buy) | 134.7k | $1.00 | $134.7k | | 03/05/2013 |
|